New drug candidate SCB0020160 enters first human safety tests
Knowledge-focused
Not yet recruiting
This phase 1 trial tests a new investigational drug, SCB0020160, for the first time in humans. Healthy adult men aged 18 to 65 receive either the drug or a placebo to evaluate safety, tolerability, and how the drug moves through the body. The study also looks at whether food affe…
Phase: PHASE1 • Sponsor: SCBIO Inc. • Aim: Knowledge-focused
Last updated Jul 03, 2026 19:21 UTC